baber/WOPTO huggingface dataset:
Patent JP-2002509531-A (JP)
IPC: A61K41/00
Filed: 1998-01-14
Abstract: A method for reducing or preventing the effects of inflammation arising from injured tissue, which method comprises the steps of:a. bringing the injured tissue, or pre-injured tissue, into contact with a photosensitizing agent capable of penetrating into the tissue, resulting in the desired degree of biodistribution in less than one hour; andb. exposing the tissue thus contacted to light having a wavelength absorbed by the photosensitizing agent for a time sufficient to reduce or prevent inflammation in the exposed tissue, but not so long as to cause necrosis or erythema of the exposed tissue,or a pharmaceutical composition or an article for reducing or preventing the effects of inflammation arising from injured tissue.The composition comprises:a. from about 1 mug/mL to about 2 mg/mL of a photosensitizing agent capable of penetrating into the injured tissue, or pre-injured tissue, resulting in the desired degree of biodistribution less than one hour; andb. a pharmaceutically acceptable carrier.The article comprises:a. a photosensitizing agent capable of penetrating into the injured tissue, or pre-injured tissue, resulting in the desired degree of biodistribution in less than one hour; andb. an absorbent applicator.
Patent JP-H11506483-A (JP)
Title: 同時的なエポキシ化および触媒残留物の抽出
IPC: C08C19/06
Filed: 1996-05-15
Abstract: (57)【要約】
第ＶＩＩＩ族金属触媒を用いて水素化されたアニオン重合ジエン含有ポリマーのエポキシ化および該ポリマーからの触媒残留物の抽出を同時に行う方法であって、（ａ）触媒残留物を含有するジエン含有ポリマーセメントを反応器中に導入し、（ｂ）このポリマーセメントを２５〜６５℃の温度に加熱し、（ｃ）このポリマーセメントを苛性アルカリ溶液と接触させ、（ｄ）このポリマーセメントを過酸溶液と接触させ、（ｅ）これらのポリマー、苛性アルカリおよび酸を２５〜６５℃にて１／２〜３時間混合し、（ｆ）随意に、混合を続行しながら過剰の酸を中和するのに十分な苛性アルカリ溶液を添加し、（ｇ）混合を続行しながら水性相／有機相の重量比が０．２：１ないし１：１になるように十分な水を添加し、（ｈ）５〜９０分間相を沈降分離させ、（ｉ）水性相を反応器から除去し、（ｊ）随意に、触媒残留物分が１０ｐｐｍ未満になるまで工程（ｇ）、（ｈ）および（ｉ）を繰り返し、そして（ｋ）ポリマーセメントを反応器から取り出しそして溶媒を除去してエポキシ化ポリマーを回収することからなる上記方法。
Patent JP-2000508254-A (JP)
IPC: B29C48/90
Filed: 1997-04-04
Abstract: A method for making a product to be extruded and an extruder. The extruder has at least two conical stators and at least one conical rotor placed rotatably between the stators. The extruder further has supply conduits for feeding the material to be extruded separately into the exterior and interior of the rotor. Each supply conduit is provided with a separately adjustable feeding device by means of which the amount of material flow to be supplied can be adjusted. The degree to which the space between the rotor and the stator is filled and the amount of the heat generated by friction can be regulated. Further, the ratio of the material flows in the different supply conduits determines the ratio of the thickness of the layers obtained. The method and extruder according to the invention make it possible to regulate the properties of a final product easily and in several different ways.
Patent JP-2001525086-A (JP)
Title: 集積されたｓｒａｍおよびシステムを備えたｄｒａｍとその利用法
IPC: G06F12/08
Filed: 1998-03-13
Abstract: (57)【要約】
メモリ４００は複数個のバンク４０１およびグローバル・アクセス制御回路４０６を有する。複数個のバンクのおのおのはメモリ・セルの第１アレイおよび第２アレイ５０６、４０２と、アドレス・ビットに応答して第１アレイの中のセルを選択的にアクセスするための第１アクセシッング回路４１３、５０７と、アドレス・ビットに応答して第２アレイの中のセルを選択的にアクセスするための第２アクセシッング回路４０４、４１３とを有する。バンク４０１のおのおのの中のストレージ回路５０２は以前に受け取られたアドレス・ビットを記憶する。バンクのおのおのの中の比較のための回路５０３は受け取られたアドレス・ビットとストレージ回路５０３の中の記憶されたアドレス・ビットとを比較し、記憶されたアドレス・ビットが受け取られたアドレス・ビットと整合する時に第１アクセシッング回路４１３、５０７が記憶されたアドレス・ビットによりアドレスされた第１アレイ５０６の中のセルをアクセスし、および記憶されたアドレス・ビットが受け取られたアドレス・ビットとは異なる時に第２アクセシッング回路４０４、４１３が受け取られたアドレス・ビットによりアドレスされた第２アレイ４０２の中のセルをアクセスする。グローバル・アクセス制御回路４０６は、複数個のバンク４０１の選定されたバンクの中の受け取られたアドレスと記憶されたアドレスとの比較をイネーブルにする。
Patent JP-2000510039-A (JP)
Title: オゾン分解用の触媒反応器
IPC: B01J15/00
Filed: 1997-05-09
Abstract: (57)【要約】
空気中のオゾンを分解するための触媒反応器が提供される。この反応器は、オゾン含有空気の流れを受け入れるのに有効な入口端部と、そこからオゾン含有空気を排出するのに有効な出口端部とを有するコア構造体を含む。このコア構造体は、コア構造体の入口端部と出口端部との間を流れるオゾン含有空気中に存在するオゾンの少なくとも一部を分解するのに有効である触媒的に活性な合金から作られる。この触媒的に活性な合金は銀含有合金を含み、主成分として銀及び銅を有する合金を含むことができる。この触媒的に活性な合金は、低温用途で使用するために、熱的に活性化することができる。コア構造体は、そのコア構造体の入口端部と出口端部との間に複数の曲がりくねった流路を提供するように配置され、オゾン含有空気の曲がりくねった流れを促進する。
Patent JP-2001516281-A (JP)
Title: 郵便小荷物の表面の記号および文字を認識する方法
IPC: G06K9/20
Filed: 1998-03-16
Abstract: (57)【要約】
小包（Ｐ）の表面の記号および文字を検出するために、民生用のビデオカメラ（ＶＫ）を使用する。このカメラ（ＶＫ）の観察領域（Ｂ１〜Ｂｎ）は、回転鏡装置（ＤＳ）を介して前記表面に渡って配向され、これによりタイル状に分割された多数の観察領域（Ｂ１〜Ｂｎ）から、全体画像を求める。
Patent JP-2000511462-A (JP)
Title: 水中―溶剤型エマルジョンを用いた塗料オーバースプレイシステムから気化性の有機化合物を回収する方法
IPC: C08J11/02
Filed: 1997-05-15
Abstract: (57)【要約】
使用済の水中ー溶剤型エマルジョンを塗料オーバースプレイ処理および捕集システムから除去して反応容器中に供給するようになされた塗料オーバースプレイ処理および捕集システムから生じる使用済の水中ー溶剤型エマルジョンからカルボニル化合物の相当量を回収する方法。使用される反応容器は反応室を形成する外側ハウジングとこの反応室中に移動可能に設けられた多数の混合翼とを有する。これらの混合翼の表面領域をカルボニル化合物を気化させるのに充分な温度に維持する。反応容器の内部は真空下に維持する。使用済の水中ー溶剤型エマルジョンは気化されるカルボニル化合物を生じるのに充分な時間にわたって反応容器中で処理される。生成された気化カルボニル化合物をリサイクルおよび再使用のために反応容器から除去し、そして気化されたカルボニル化合物物質の生成後に反応容器中に残存する固体残渣物を除去する。本発明の溶剤回収方法によって処理することのできる使用済の水中ー溶剤型エマルジョンは第二級アルコールエステル、第二級アルコールエステル誘導体およびそれらの混合物からなる群より選ばれ、少なくとも１５０℃の沸点および２０℃における約０．５Ｔｏｒｒの間の蒸気圧を有するカルボニル化合物を含む。カルボニル回収方法によって生成される使用済の水中ー溶剤型エマルジョンは予め脱水されて水がほとんど又は全く残存しない使用済の水中ー溶剤型エマルジョンを生成させることができ、又は存在するエマルジョンの水のほとんどの部分又は全部と共に処理することができる。これらの場合には、水分はカルボニル化合物と同時に生じさせてもよい。
Patent JP-2001519022-A (JP)
Title: 微小物の高解像度ｘ線撮像方法
IPC: H01J35/00
Filed: 1998-04-08
Abstract: (57)【要約】
サンプル用チャンバー（１２）を形成する構造体（１１）と、該構造体に装着されていて、Ｘ線（６）を発生させるための特定の入射ビーム（５）によって励起しやすい物質（２０）とからなるＸ線撮像用サンプルセル（１０）であって、前記セルが、放射されたＸ線（６）の少なくとも一部がチャンバー（１２）を透過してサンプル（７）を照射し、その後セル（１０）を出て検出器（３５）へ到達するように配置されてなるＸ線撮像用サンプルセル（１０）。
Patent JP-2001519909-A (JP)
Title: 位置ずれエラー修正および適応照明を備えた改良形表面検査システム
IPC: G01B11/30
Filed: 1998-04-08
Abstract: (57)【要約】
光学表面検査システム（２０）は位置ずれエラーを修正する目的のものである。データサンプルの参照ベクトルは、隣接するデータサンプルのベクトルの平均を計算することにより得られる。処理中の現在のベクトルのデータサンプルを現在のベクトルの方向に沿って現在のベクトルからオフセットされるデータサンプルと比較することによって、位置ずれエラーを検出し修正できる。その代わりに、データサンプルの標的アレイは、種々のオフセットで表面（４０）の異なる部分から収集されたデータサンプルの参照アレイと比較され、位置ずれエラーを検出し修正する。検査ビーム（２４）からの反射強度をモニタして検査ビームの強度を変え、広範囲の背景散乱を減少させる。
Patent JP-2001526013-A (JP)
Title: 移動通信システムにおける電力制御
IPC: H04W52/00
Filed: 1998-05-15
Abstract: (57)【要約】
本発明は、無線経路での１つの論理接続の信号伝送が、例えば周波数ホッピング、アンテナホッピング、もしくは、タイムスロットホッピングといったホッピングを使用するような移動通信システムにおける電力制御方法に関する。本発明の方法によると、本方法は、無線接続で受信された信号の品質が、例えば周波数、アンテナ、もしくは、タイムスロットといった１つのホッピングセッティングで決定され、そして、電力制御は、当無線接続でホッピングセッティング毎に実行され、例えば周波数といった少なくとも１つのホッピングセッティングの電力は、同一の無線接続で使用される、例えば周波数といった少なくとも１つの他のホッピングセッティングの伝送電力とは異なるようにすることを特徴とする。
Patent MD-20000149-A (MD)
Title: Self-running spring-loaded engine
Inventor: POPUŞOI Leonid
IPC: F03G7/10
Filed: 2000-09-08
Abstract: The engine comprises a wheel 2 coupled with a body 1 by an axis 6. A spring 3 is coupled with the wheel 2 by an axis 7 and with the body 1 - by an axis 9. The spring 3 is functioning in the gravitation regime. The spring 3 draws the wheel 2 from the A point up to the B one by compressing the spring 4. In the B point the spring 4 is detached and the wheel 2 is moving up to the axis 8 reaching the C point. At that time the power of the spring 4 is transferred to the spring 5. In the C point the spring 5 is connected to the axis 8 and pushes the wheel upwards to the A1 point. The B point is situated closer to the axis 6 then the C point.For running action the engine stands in need of take-off position.Instead of the spring 5 it is used a mechanism transferring the power of the spring 4 to the C point.
Patent MX-149829-A (MX)
Inventor: BAUMAN BERNARD DANIEL
IPC: C08F2/18
Filed: 1979-06-05
Abstract: Wall fouling during the suspension polymerization of vinyl chloride containing monomers in stainless steel reactors can be inhibited by wetting the surface(s) of the reactor with a solution containing from 3 to 50 parts by weight of alkali metal hydroxide prior to charging the reactor.
Patent MX-160497-A (MX)
Inventor: KING MICHAEL JOHN
IPC: B29D30/56
Filed: 1984-07-13
Abstract: A method and apparatus for sealing a tyre retreading envelope [11] against a tyre carcass [12] for valcanization of a new tread portion [13] onto the carcass utilizes a rigid circular ring [18] and a series of clamps [19] on the ring for clamping the ring tightly onto the exterior of the tyre carcass' bead [16] with the envelope sandwiched between the ring and bead. With a ring clamped onto each bead of the tyre, air or other gases are prevented from passing when the envelope is evacuated and the tyre goes through a valcanization process. Centring pins [22] are preferably included on the ring for engaging the bead and assuring that the ring is coaxial with the tyre.
Patent NZ-180698-A (NZ)
Title: Device for disseminating vapourisable material at predetermined rate
Inventor: BROOKS TW
IPC: B65D85/82
Filed: 1976-04-27
Abstract: A device for controlling the release of vapors such as insect attractants, insecticides, and other vapors such as flower fragrances (the release being a timed matter in accordance with a predetermined configuration of the device), consisting of a microdispenser for accurately controlled dissemination of vaporizable materials comprising an elongated conduit of regulated cross-sectional area and length, and a vaporizable substance enclosed in said conduit.  The filamentary conduit has one open and one closed end.  In another variant, a filamentary conduit can be sealed between two open ends to provide a pair of end-to-end closed end conduits.  The vapor producing substance is placed in the capillary conduit by suitable means.  A single filamentary tube may be used, or a plurality of such tubes together.  Liquid is contained within the conduit against the action of gravity and vibrations.
Patent NZ-213245-A (NZ)
Title: Controlled-release coated pharmaceutical tablets
Inventor: LINDAHL A R
IPC: A61K9/28
Filed: 1985-08-27
Abstract: The present invention concerns a novel pharamceutical preparation having a biphasic release pattern. The preparation comprises a tablet core containing a drug. The tablet is coated with a coating essentially consisting of a film-forming water-insoluble polymer having fine water soluble particles randomly distributed therein. The fine particles include a drug active substance, which is the same as the drug in the core. The drug active substance in the particles may also be different from the one in the tablet core.
Patent NZ-213432-A (NZ)
Title: Antihypertensive dipeptide derivatives and pharmaceutical compositions
Inventor: NEISS E S
IPC: C07K5/065
Filed: 1985-09-11
Abstract: Compounds having the general structure <CHEM> and their pharmaceutically acceptable salts, wherein the substituents are defined herein, which exhibit antihypertensive activity.
Patent NZ-229730-A (NZ)
Title: Substituted fused quinoxaline derivatives: pharmaceutical compositions and methods of treatment
Inventor: JACOBSEN POUL
IPC: C07D517/04
Filed: 1989-06-27
Abstract: Heterocyclic dihydroxyquinoxaline compounds having the formula <CHEM> wherein R<1> and R<2> independently are hydrogen, NO2, NH2, CN, halogen, SO2NH2;  -X-Y-Z- is selected from -N=N-NR<3>-,-NR<3>-N=N-,=N-NR<3>-N=,-S-CH=N-,-N=CH-S-,-CH=C(CO2R<3>)-S -,-S-C(CO2 R<3> )= CH -, =N-Se-N=, -N=CR<3>-NR<3> -,-NR<3>-CR<3>=N-,=N-O-N=, -N=CR<3>-CR<3> =N-,-NH-CR<3>=CR<3>-CR<3>=N-,-N=CR<3>-CR<3>=CR<3>-NH,=N-S-N=;  wherein R<3> is hydrogen, lower alkyl, CF3. The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use. The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters.
Patent NZ-233179-A (NZ)
Title: Selectively blocking dopamine neurones using 5-chloro-1-(4-fluorophenyl) -3-(2(2-imidazolinon-1-yl)ethyl-4-piperidyl)-1-h-indole (lu 23-174)
Inventor: PERREGAARD JENS
IPC: A61K31/415
Filed: 1990-04-03
Abstract: Described is the use of 5-chloro-1-(4-fluorophenyl)-3-(1-(2-(2-imidazolidinon-1-yl)ethyl)-4-pi peridyl)-1H-indole , or a pharmaceutically acceptable acid addition salt thereof, for the manufacturing of a pharmaceutical composition selectively blocking dopamine neurones in the ventral tegmental area in the brain, substantially without inhibiting the activity of dopamine neurones in substantia nigra pars compacta.
Patent NZ-236545-A (NZ)
Title: Protein having cytotoxic lymphocyte maturation factor (clmf) activity; dna encoding it; recombinant vector: microorganism transformed with the vector: antibodies to clmf: and pharmaceutical compositions
Inventor: CHIZZONITE RICHARD ANTHONY
IPC: C12N15/09
Filed: 1990-12-19
Abstract: The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to cloned genes coding for CLMF proteins and derivatives thereof, to recombinant vectors comprising a polynucleotide encoding a CLMF protein, to microorganisms transformed with the said recombinant vectors, to antibodies directed to the said proteins as well as to processes for the preparation of the said proteins, vectors and antibodies. Furthermore the present invention relates to methods for stimulating LAK cells, T-cells or Natural Killer Cells using the said CLMF protein.
Patent NZ-248761-A (NZ)
Title: Isoquinoline derivatives; preparation and pharmaceutical compositions
Inventor: LAL BANSI
IPC: C07D401/12
Filed: 1993-09-24
Abstract: Described are guanidinocarbonyl isoquinolines I, <CHEM> with R(1) hydrogen, (amino)(cyclo)(aryl)alk(en)yl, (heteroaryl); R(2) hydrogen, halogen, alkyl, or Aryl; G <CHEM> X(2), X(3) and X(4) hydrogen, halogen, nitro, amino, alkyl, sulfonamide, (mono)(di)(lower alkyl)(amino), benzyloxy, hydroxy; X(1) hydrogen, oxygen, sulfur and NR(7)R(8), and their pharmaceutically acceptable salts; described is also the process for their prepara-tion, their use as medicaments, and medicaments containing them for treating congestive heart failure, arrhythmic conditions as well as cardioprotective agents in mammals.
Patent NZ-251320-A (NZ)
Title: Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
Inventor: KHARAZMI ARSALAN
IPC: C07C69/007
Filed: 1993-03-08
Abstract: The invention is drawn to novel bis-aromatic a,beta-unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
Patent NZ-261053-A (NZ)
Title: Signal controlled phase shifter
Inventor: GOLDENBERG YOAV
IPC: H03K5/13
Filed: 1993-12-22
Abstract: A clock is phase shifted by an amount controlled by the value of a control signal by establishing at least several discrete delay times to be imposed on the clock. The control signal value controls selection of the imposed discrete delay time. An analog-to-digital converter of a phase locked loop responds to intelligence representing variable phase bits and the selected phase shifted clock to control the signal value. The selected replica is derived by at least several cascaded substantially equal time delay units. In one embodiment, a multiplexer responds to the clock, and the signal value, which is Gray coded, to control connections from one of the delay units to an output terminal. In another embodiment, the number of cascaded delay units interposed between the clock and an output terminal is controlled by the signal value.
Patent NZ-266828-A (NZ)
Title: Electrochemical metal analysis apparatus having a laminated electrode comprising a mercury-containing layer
Inventor: BIRCH STEPHEN
IPC: G01N27/333
Filed: 1994-05-27
Abstract: PCT No. PCT/GB94/01167 Sec. 371 Date Sep. 8, 1995 Sec. 102(e) Date Sep. 8, 1995 PCT Filed May 27, 1994 PCT Pub. No. WO94/28401 PCT Pub. Date Dec. 8, 1994Electrochemical heavy metal analysis includes a printed electrode having a layer of a mercury compound or salt supported thereon. The compound or salt is reduced to metallic mercury in use of the electrode. The mercury layer may comprise a layer of hydroxyethyl cellulose or other permeable polymer.
Patent NZ-277415-A (NZ)
Title: Metal-ion chelates bound to acidic saccharide carrier having selective oligosaccharide oversulphation
Inventor: RANNEY DAVID F
IPC: A61K49/18
Filed: 1994-11-29
Abstract: This application concerns novel agents comprising cationic or chemically basic metal chelators in association with hydrophilic carriers of anionic or chemically acidic saccharides, sulfatoids and glycosaminoglycans. In certain embodiments, the agents comprise metals and metal ions. Covalent and non-covalent chemical and physical means are described for stabilizing the binding of the metal chelators to the carriers. Novel non-covalently bound compositions are described which give uniquely high payloads and ratio of metal chelator to carrier, ranging from a low of about 15% metal chelator by weight, to a characteristic range of 70% to 90% metal chelator by weight. Specific embodiments are described comprising deferoxamine, ferrioxamine, iron-basic porphine, iron-triethylenetetraamine, gadolinium DTPA-lysine, gadolinium DOTA-lysine and gadolinium with basic derivatives of porphyrins, porphines, expanded porphyrins, Texaphyrins and sapphyrins as the basic or cationic metal chelators, which are in turn, bound to acidic or anionic carriers, including one or more of acidic or anionic saccharides, and including sulfated sucrose, pentosan polysulfate, dermatan sulfate, oversulfated dermatan sulfate, chondroitin sulfate, oversulfated chondroitin sulfate, heparan sulfate, beef heparin, porcine heparin, non-anticoagulant heparins, and other native and modified acidic saccharides and glycosaminoglycans. Also disclosed are methods of enhancing in vivo imgages arising from induced magnetic resonance signals, methods of enhancing in vivo images in conjunction with ultrasound or X-rays and methods of obtaining in vivo body images utilizing radioisotope containing agents. Methods of treating vasular disease are also disclosed.
Patent NZ-334172-A (NZ)
Title: Non-gelled and whipped refrigerated product with predetermined portions of emulsifier, xantham gum, carageenan and microcrystalline cellulose
Inventor: GRAHAM JUDITH
IPC: A23L29/262
Filed: 1999-02-12
Abstract: The product contains between 0.2 and 0.5% emulsifier, between 0.1 and 0.6% xantham gum, between 0.1 and 0.3% carragenan, and between 0.2 and 0.8% microcrystalline cellulose.
Patent NZ-500284-A (NZ)
Title: Type II TGF-beta receptor fusion proteins
Inventor: GOTWALS PHILIP
IPC: C07K19/00
Filed: 1998-04-16
Abstract: Fusion proteins comprising the TGF-beta Type II receptor linked to a portion of an immunoglobulin constant chain are described. Also described is the use of the fusion proteins to treat a variety of fibroproliferative disorders.
Patent NZ-503444-A (NZ)
Title: Process for the purification of an used alkanolamine using a two step distillation process carried out in at least one film type evaporator
Inventor: VAN GRINSVEN PETRUS FRANCISCUS
IPC: B01D53/14
Filed: 1998-10-26
Abstract: A process for the purification of an aqueous alkanolamine, which has been used in an absorption or extraction process in the oil or chemical industry, comprises subjecting the alkanolamine to a distillation process. The distillation process, which is carried out in one or more film type evaporators, comprises at least two steps wherein in the first step water is removed from the aqueous alkanolamine and in the second step the dewatered alkanolamine is further purified.
Patent NZ-506537-A (NZ)
Title: Roof construction includes ridge member having channels and valley member having carriers mounted either side of a central member
Inventor: RICKMAN PAUL DOUGLAS
IPC: E04B7/04
Filed: 1999-03-12
Abstract: A conservatory roof construction comprises a ring beam 10 adapted to be laid around the upper surfaces of the conservatory walls, a ridge member 12, a plurality of glazing bars 13 extending between ridge member 12 and ring beam 10.  A valley member 17 is disposed between two sections of the roof lying in different planes and also extends between ridge member 12 and ring beam 10.  Ridge member 12 comprises a central member 30 and a pair of ridge channels 31, 32 disposed one to each side of the member.  Ridge channels 31, 32 define surfaces for supporting the ridge ends of glazing bars 13.  Valley member 17 comprises a central member 55, a pair of carriers 57 mounted one to each side of central member 55 for supporting the lower ends of glazing bars terminating along the valley.  Central member 30 of ridge member 12 is of substantially the same configuration as central member 55 of valley member 17.
Patent NZ-508625-A (NZ)
Title: Seawater corrodible link
Inventor: RUSSELL EDWIN ROBIN
IPC: A01K69/06
Filed: 1998-06-25
Abstract: A corrodible link for delayed release upon exposure to seawater comprising a first U-shaped metallic element (170) with its ends (174,176) spaced apart from one another when unstressed, and a second metallic element (172) that is placed over the ends of element (170) to draw them together and form a loop. Element (172) is electro-chemically dissimilar to the first metallic element (170) and adapted to sacrificially corrode in seawater such that after a prescribed corrosion, the force exerted by the ends (174,176) of the first element (170) fractures the second element (172) and opens the loop
Patent NZ-508789-A (NZ)
Title: Method for causticising sodium carbonate by reaction with lime in an aqueous solution to form sodium hydroxide in the presence of sodium borate
Inventor: MCBROOM ROBERT B
IPC: D21C11/04
Filed: 1999-05-28
Abstract: A method is provided for improving causticising efficiency in the conventional lime recausticisation portion of an alkaline pulping process.  Such processes are commonly used in the pulping and bleaching of wood and non-wood cellulose fibre materials.  The method comprises reacting an aqueous solution of sodium carbonate with lime to produce sodium hydroxide (causticisation) in the presence of borate in order to improve the causticisation reaction efficiency.  Borate is added in an amount sufficient to provide a boron to sodium (B/Na) molar ratio in the range of between 0.001:1 and 0.4:1, and preferably in the range of between 0.01:1 and 0.3:1, which results in an increased causticisation efficiency of up to 8% over the reaction efficiency obtained in the absence of borate. Depicted is a graph of causticising efficiency of a pure sodium carbonate solution as a function of time in the presence of and in the absence of boron at 80-90 oC.
Patent NZ-510768-A (NZ)
Title: A method of luring an animal to a predetermined place
Inventor: VERBURG CARLO
IPC: A01K1/12
Filed: 2000-07-18
Abstract: A method of luring an animal to a predetermined place, such as e.g. a milking stall and/or a feeding stall, where the animal lured undergoes a predetermined treatment, and/or a predetermined animal-related action, such as e.g. milking and/or feeding, is performed, whereby, at least during a predetermined stage of the treatment and/or the action, at least one previously defined climate parameter is set artificially in at least one part of the relevant place.
Patent NZ-511004-A (NZ)
Title: Use of dithiocarbamate ester to treat cardiovascular or inflammatory diseases
IPC: A61K31/27
Filed: 1995-05-10
Abstract: A dithiocarbamate ester of formula ASC(S)B which prevents or minimizes the oxidation of a polyunsaturated fatty acid is used to treat cardiovascular disease or inflammatory disease wherein: A is a physiologically cleavable leading group other than a pharmaceutically acceptable cation; B is NR2R3; R2 and R3 are independently alkyl, (CHOH)n(CH2)nOH, -(CH2)n-CO2R4, hydroxyalkyl, alkenyl, alkyl-CO2H, alkenyl-CO2H, alkynyl-CO2H or aryl optionally substituted by NO2, CH3, t-butyl, CO2H, halo or p-OH or together R2 and R3 can form a bridge; n is 0 to 6 and R4 is alkyl, aryl, alkaryl, and aralkyl.
Patent NZ-511550-A (NZ)
Title: CCK-B/gastrin receptor inhibitors for the treatment of tumors
Inventor: MICHAELI DOV
IPC: C07K14/72
Filed: 1998-05-12
Abstract: Use of an immunogen comprising a CCK-B/gastrin immunomimic receptor peptide having the amino acid sequence: (i) KLNRSVQGTGPGPGASL, or (ii) GPGAHRALSGAPISF, conjugated to an immunogenic carrier protein, for the preparation of a medicament for treating a malignant condition caused by a gastrin-dependent malignant cell growth. (62) Divided Out of 500748